132 related articles for article (PubMed ID: 9689500)
1. Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungals.
Talele TT; Hariprasad V; Kulkarni VM
Drug Des Discov; 1998 May; 15(3):181-90. PubMed ID: 9689500
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agents.
Talele TT; Kulkarni VM
J Chem Inf Comput Sci; 1999; 39(2):204-10. PubMed ID: 10192939
[TBL] [Abstract][Full Text] [Related]
3. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.
Lewis DF; Wiseman A; Tarbit MH
J Enzyme Inhib; 1999; 14(3):175-92. PubMed ID: 10445042
[TBL] [Abstract][Full Text] [Related]
5. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Sheng C; Zhang W; Ji H; Zhang M; Song Y; Xu H; Zhu J; Miao Z; Jiang Q; Yao J; Zhou Y; Zhu J; Lü J
J Med Chem; 2006 Apr; 49(8):2512-25. PubMed ID: 16610794
[TBL] [Abstract][Full Text] [Related]
6. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
7. New azoles with potent antifungal activity: design, synthesis and molecular docking.
Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408
[TBL] [Abstract][Full Text] [Related]
8. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii.
Babazadeh-Qazijahani M; Badali H; Irannejad H; Afsarian MH; Emami S
Eur J Med Chem; 2014 Apr; 76():264-73. PubMed ID: 24583607
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of New Antifungals Based on N-Un-substituted Azoles as 14α Demethylase Inhibitor.
Davood A; Rahimi A; Iman M; Azerang P; Sardari S; Mahboubi A
Curr Comput Aided Drug Des; 2021; 17(2):235-243. PubMed ID: 32065093
[TBL] [Abstract][Full Text] [Related]
10. New azoles with antifungal activity: Design, synthesis, and molecular docking.
Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
[TBL] [Abstract][Full Text] [Related]
11. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.
Doğan İS; Saraç S; Sari S; Kart D; Eşsiz Gökhan Ş; Vural İ; Dalkara S
Eur J Med Chem; 2017 Apr; 130():124-138. PubMed ID: 28242548
[TBL] [Abstract][Full Text] [Related]
12. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.
Hitchcock CA; Dickinson K; Brown SB; Evans EG; Adams DJ
Biochem J; 1990 Mar; 266(2):475-80. PubMed ID: 2180400
[TBL] [Abstract][Full Text] [Related]
13. How do azoles inhibit cytochrome P450 enzymes? A density functional study.
Balding PR; Porro CS; McLean KJ; Sutcliffe MJ; Maréchal JD; Munro AW; de Visser SP
J Phys Chem A; 2008 Dec; 112(50):12911-8. PubMed ID: 18563875
[TBL] [Abstract][Full Text] [Related]
14. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Emami S; Tavangar P; Keighobadi M
Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers.
Lamb DC; Kelly DE; Baldwin BC; Gozzo F; Boscott P; Richards WG; Kelly SL
FEMS Microbiol Lett; 1997 Apr; 149(1):25-30. PubMed ID: 9103974
[TBL] [Abstract][Full Text] [Related]
16. Classical QSAR study on chromene derivatives as lanosterol 14alpha- demethylase inhibitor: a non azole antifungal target.
Vasanthanathan P; Lakshmi M; Babu MA; Kaskhedikar SG
Med Chem; 2006 Jul; 2(4):363-7. PubMed ID: 16848747
[TBL] [Abstract][Full Text] [Related]
17. Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies.
Tafi A; Costi R; Botta M; Di Santo R; Corelli F; Massa S; Ciacci A; Manetti F; Artico M
J Med Chem; 2002 Jun; 45(13):2720-32. PubMed ID: 12061875
[TBL] [Abstract][Full Text] [Related]
18. Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design.
Monk BC; Sagatova AA; Hosseini P; Ruma YN; Wilson RK; Keniya MV
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140206. PubMed ID: 30851431
[TBL] [Abstract][Full Text] [Related]
19. Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.
Rupp B; Raub S; Marian C; Höltje HD
J Comput Aided Mol Des; 2005 Mar; 19(3):149-63. PubMed ID: 16059669
[TBL] [Abstract][Full Text] [Related]
20. Sterol 14 alpha-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 alpha-demethylase (P-450(14DM)) of yeast.
Yoshida Y; Aoyama Y
Biochem Soc Trans; 1991 Aug; 19(3):778-82. PubMed ID: 1783215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
